Latest market price
16.53
-0.06-0.36%
HTGCQT46Hercules Capital, Inc.·NYSE
16.53-0.36%
TA
Loading chart...
Signal & projected range
Analyst consensus risingHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index—P/E8.98EPS (ttm)1.84Insider Own2.28%Shs Outstand187.16MPerf Week0.73%
Market Cap3.09BForward P/E8.50EPS next Y1.95Insider Trans0.00%Shs Float171.51MPerf Month-1.25%
Enterprise Value5.61BPEG5.72EPS next Q0.49Short Float6.31%Perf Quarter-2.07%
Income358.00MP/S5.55EPS this Y-0.23%Short Ratio7.50Perf Half Y0.55%
Sales557.00MP/B1.33EPS next Y1.11%ROA7.21%Short Interest10.83MPerf YTD-12.17%
Book/sh12.42P/C64.44EPS next 5Y1.57%ROE15.80%52W High19.13 -13.59%Perf Year-6.03%
Cash/sh0.26P/FCF—EPS past 3/5Y32.79% -1.65%ROIC9.01%52W Low13.70 20.66%Perf 3Y8.04%
Dividend Est.1.88 (11.37%)EV/EBITDA12.75Sales past 3/5Y31.78% 8.91%Gross Margin93.83%Volatility1.56% 1.62%Perf 5Y-5.76%
Dividend TTM1.95 (11.80%)EV/Sales10.07EPS Y/Y TTM6.98%Oper. Margin79.11%ATR (14)0.29Perf 10Y21.45%
Dividend Ex-DateNov 10, 2026Quick Ratio1.41Sales Y/Y TTM13.44%Profit Margin64.13%RSI (14)47.41Recom2.42
Dividend Gr. 3/5Y1.99% 8.66%Current Ratio1.41EPS Q/Q-4.08%SMA200.35%Beta0.74Target Price15.50
Payout94.96%Debt/Eq1.10Sales Q/Q-13.61%SMA50-2.76%Rel Volume1.39Prev Close16.59
Employees100LT Debt/Eq1.10EarningsFeb 11SMA2002.38%Avg Volume1.37MPrice16.53
IPO DateJun 09, 2005Option/ShortYes / YesEPS/Sales Surpr.-1.02% -2.77%Net Debt/EBITDA5.72Volume1,900,811Change-0.36%
Analyst Ratings
DateActionAnalystRatingTarget
Sep-01-26UpgradeUBSNeutral → Buy
May-18-26ReiteratedUBSNeutral$19 → $16
Feb-13-26DowngradePiper SandlerOverweight → Neutral$21 → $18
Dec-15-25InitiatedLucid CapitalBuy$20
Nov-04-25UpgradeCompass PointNeutral → Buy$20
Oct-14-25ReiteratedUBSNeutral$20 → $19
Oct-09-25ReiteratedPiper SandlerOverweight$22 → $21
Dec-12-24UpgradeKeefe, Bruyette & WoodsMarket Perform → Outperform
Jul-18-24ReiteratedUBS$19 → $20
Jul-10-24ReiteratedPiper SandlerOverweight$22
Latest News· Times ET
Nov-01-26
Oct-30-26
Oct-30-2605:15PM
Oct-29-26
Oct-27-26
Oct-26-26
Oct-24-26
Oct-22-26
Oct-21-26
Oct-20-26
Oct-19-26
Company

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $500 million in equity per transactions. It invests in debt between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue557547431494—————
Cost of Goods Sold Incl. D&A48707768—————
Gross Profit523477354426—————
Selling, General and Administrative Excl. Other33192019—————
Research and Development
0000—————
Other Operating Expense48937170—————
Operating Income440365263337—————
Interest Expense111927768—————
Unusual Expense
—————————
Non-Operating Income (Expense)28677768—————
Net Income Before Taxes358340263337—————
Income Taxes
0000—————
Consolidated Net Income358340263337—————
Net Income From Continuing Operations358340263337—————
Net Income358340263337—————
EPS (Recurring)1.931.901.612.32—————
EPS (Basic, Before Extraordinaries)1.931.901.612.32—————
EPS (Diluted)1.841.851.612.31—————
EBITDA440365263338—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio8.9810.1712.487.22—————
Price To Sales Ratio5.526.237.504.86—————
Gross Margin93.9087.2082.1386.23—————
Operating Margin78.9966.7361.0268.22—————
Net Margin64.2762.1661.0268.22—————
Shares Outstanding186181161144—————
Market Capitalization3,0753,4063,2342,400—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$20.38$18.54$16.71$14.88$13.04● Close Price0.00M0.46M0.93M1.39M1.85MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
BADAVAS ROBERT PDirectorMar 26 '26Buy14.353,65852,4925,070Mar 30
Loo WadeDirectorMar 26 '26Buy14.357,317104,99914,050Mar 30
Fallon Thomas JDirectorMar 26 '26Buy14.307,300104,390157,669Mar 30
Aguirre DeAnneDirectorMar 26 '26Buy14.357,317104,99910,749Mar 30
Randhawa Paramjeet KDirectorMar 26 '26Buy14.352,92641,98822,486Mar 30
CROWELL GAYLE ADirectorMar 26 '26Buy14.357,317104,99997,589Mar 30
Theodosopoulos NikosDirectorMar 26 '26Buy14.357,317104,99929,362Mar 30
Follmann ChristianChief Operating OfficerMar 04 '26Buy14.6810,000146,800150,135Mar 05
Randhawa Paramjeet KDirectorMar 04 '26Buy14.783,05045,07919,560Mar 05
Theodosopoulos NikosDirectorFeb 27 '26Buy14.212,60036,94621,523Feb 27
BADAVAS ROBERT PDirectorFeb 27 '26Buy14.275,00071,350122,073Feb 27
Botelho Kiersten ZazaChief Legal Officer & CCOFeb 27 '26Buy14.211,30018,47393,336Feb 27
Fallon Thomas JDirectorFeb 27 '26Buy14.2020,000284,000150,369Feb 27
Meyer Seth HChief Financial OfficerFeb 27 '26Buy14.337,000100,310448,553Feb 27
Bluestein ScottChief Executive OfficerFeb 27 '26Buy14.357,000100,4502,516,379Feb 27
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.